ArticleBiomedicines2024

Pan-Cancer Analysis Reveals the Potential of PLOD1 as a Prognostic and Immune Biomarker for Human Cancer.

Zhao Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.